"suggest the partial agonist profile of aplindore would not be differentiated from the full agonists which either are or will be generic by the time aplindore could be launched"

why would you put this statement in the press release?? How can you attempt to sell a drug and then say to the buyer, "well, we don't really think this drug is any good, but you still want to buy it?" Idiots...